- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有77家主力机构披露2025-06-30报告期持股数据，持仓量总计3396.61万股，占流通A股24.67%
- 波段诊断：
-
技术面诊股
诊断结果：6.9技术面打败了50%的股票
技术面评分前10的股票
近期的平均成本为19.95元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为19.95元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"19.95","date":1768724230,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.01.19","stock":"-0.84","trade":null,"ind":"0.09"},{"date":"2026.01.16","stock":"-2.23","trade":null,"ind":"-0.18"},{"date":"2026.01.15","stock":"-3.64","trade":null,"ind":"0.41"},{"date":"2026.01.14","stock":"-2.37","trade":null,"ind":"0.56"},{"date":"2026.01.13","stock":"4.83","trade":null,"ind":"-1.37"},{"date":"2026.01.12","stock":"2.85","trade":null,"ind":"1.75"},{"date":"2026.01.09","stock":"2.93","trade":null,"ind":"1.15"},{"date":"2026.01.08","stock":"2.92","trade":null,"ind":"-0.51"},{"date":"2026.01.07","stock":"-1.08","trade":null,"ind":"0.06"},{"date":"2026.01.06","stock":"-1.37","trade":null,"ind":"1.40"},{"date":"2026.01.05","stock":"7.07","trade":null,"ind":"2.24"},{"date":"2025.12.31","stock":"-0.16","trade":null,"ind":"-0.58"},{"date":"2025.12.30","stock":"-1.02","trade":null,"ind":"0.49"},{"date":"2025.12.29","stock":"-0.85","trade":null,"ind":"-0.49"},{"date":"2025.12.26","stock":"-2.39","trade":null,"ind":"0.54"},{"date":"2025.12.25","stock":"2.12","trade":null,"ind":"0.33"},{"date":"2025.12.24","stock":"0.37","trade":null,"ind":"0.88"},{"date":"2025.12.23","stock":"-0.69","trade":null,"ind":"0.27"},{"date":"2025.12.22","stock":"0.37","trade":null,"ind":"1.47"},{"date":"2025.12.19","stock":"1.18","trade":null,"ind":"0.66"},{"date":"2025.12.18","stock":"1.64","trade":null,"ind":"-1.29"}]
透景生命,深证成指,医疗器械指数
压力支撑
该股压力位为19.91元，支撑位为19.75元。
[{"text":"\u538b\u529b\u4f4d","value":"19.91","date":1768752000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.75","date":1768752000,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.9资金面打败了21%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：01月19日 20:30
| 机构今日流向(万元) | -1505.19 | 机构5日流向(万元) | -6836.20 |
| 机构10日流向(万元) | -7115.33 | 机构20日流向(万元) | -7962.42 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少289.18万股，其中基金净增仓3家，主力净增仓35家，请投资者中长期谨慎为宜。
截止2025-06-30，共77家主力机构（基金72家，一般法人5家），持仓量总计3396.61万股，占流通A股24.67%
其中，基金持仓与2024-12-31相比：
增仓：13家 ，增持 27.71万股
减仓：10家 ，减持 5.97万股
新出现在主力名单中：46家 ，持有524.15万股
从主力名单中消失：11家 ，原持有1069.07万股
其中，基金持仓与2024-12-31相比：
增仓：13家 ，增持 27.71万股
减仓：10家 ，减持 5.97万股
新出现在主力名单中：46家 ，持有524.15万股
从主力名单中消失：11家 ，原持有1069.07万股
消息面诊股
诊断结果：5.5消息面打败了42%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 继脑机接口之后，AI制药也火了？医疗器械指数ETF
2026-01-13 - 透景生命：骨髓增生异常综合征染色体及基因异常检测试
2026-01-12 - 透景生命：子公司申报医疗器械注册获得受理
2026-01-12 - 装机！“快线精灵T9”全自动流水线落地华南！
2026-01-06 - 体外诊断2025：行业承压，企业多路径求变
2025-12-31 - 透景生命完成注销部分已获授股票期权和限售股
2025-12-23 - 透景生命：公司及子公司取得1项专利证书
2025-12-23 - 透景生命：取得杂交瘤细胞株1C2B8-2及其分泌抗
2025-12-23 - 透景生命：公司研发项目持续落地，除了取得两款NMP
2025-12-22 - 透景生命子公司取得医疗器械注册证
2025-12-19
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-28 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-04-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.01.19","price":"0.09","value":null},{"date":"2026.01.16","price":"-0.18","value":null},{"date":"2026.01.15","price":"0.41","value":null},{"date":"2026.01.14","price":"0.56","value":null},{"date":"2026.01.13","price":"-1.37","value":null},{"date":"2026.01.12","price":"1.75","value":null},{"date":"2026.01.09","price":"1.15","value":null},{"date":"2026.01.08","price":"-0.51","value":null},{"date":"2026.01.07","price":"0.06","value":null},{"date":"2026.01.06","price":"1.40","value":null},{"date":"2026.01.05","price":"2.24","value":null},{"date":"2025.12.31","price":"-0.58","value":null},{"date":"2025.12.30","price":"0.49","value":null},{"date":"2025.12.29","price":"-0.49","value":null},{"date":"2025.12.26","price":"0.54","value":null},{"date":"2025.12.25","price":"0.33","value":null},{"date":"2025.12.24","price":"0.88","value":null},{"date":"2025.12.23","price":"0.27","value":null},{"date":"2025.12.22","price":"1.47","value":null},{"date":"2025.12.19","price":"0.66","value":null},{"date":"2025.12.18","price":"-1.29","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰股份 | 77.41% | 9.85% | 6.4分 |
| 2 | 宝莱特 | 76.30% | 30.25% | 5.8分 |
| 3 | 天智航 | 54.99% | 18.48% | 6.0分 |
| 4 | 乐普医疗 | 46.02% | -6.01% | 5.5分 |
| 5 | 翔宇医疗 | 44.80% | -10.54% | 4.6分 |
| 6 | 麦澜德 | 35.78% | -12.91% | 4.7分 |
| 8 | 楚天科技 | 30.21% | 3.55% | 5.2分 |
| 10 | 伟思医疗 | 28.99% | -12.13% | 5.5分 |
| 12 | 康众医疗 | 24.08% | -3.89% | 6.0分 |
| 14 | 睿昂基因 | 23.37% | 6.04% | 6.0分 |
| 16 | 康拓医疗 | 21.82% | -4.45% | 5.5分 |
| 18 | 冠昊生物 | 17.40% | -7.00% | 5.5分 |
| 20 | 硕世生物 | 16.11% | -2.97% | 6.2分 |
| 22 | 东星医疗 | 14.33% | 8.16% | 5.9分 |
| 24 | 爱威科技 | 12.90% | 2.86% | 7.1分 |
| 26 | 理邦仪器 | 12.30% | -2.63% | 5.8分 |
| 28 | 英诺特 | 11.62% | -5.85% | 5.5分 |
| 30 | 乐心医疗 | 11.40% | -1.30% | 5.6分 |
| 32 | 三友医疗 | 10.88% | 4.10% | 6.1分 |
| 34 | 艾德生物 | 10.27% | 2.93% | 5.9分 |
| 36 | 迈普医学 | 9.87% | -2.22% | 4.7分 |
| 38 | 阳普医疗 | 9.59% | -0.86% | 5.9分 |
| 40 | 山外山 | 9.54% | 0.62% | 6.3分 |
| 42 | 海尔生物 | 9.42% | 0.09% | 6.0分 |
| 44 | 欧普康视 | 9.14% | -2.46% | 4.7分 |
| 46 | 赛科希德 | 8.85% | 3.06% | 6.1分 |
| 48 | 微电生理 | 8.12% | 0.66% | 5.2分 |
| 50 | 鱼跃医疗 | 7.88% | -6.05% | 5.5分 |
| 52 | 蓝帆医疗 | 7.61% | -2.14% | 5.1分 |
| 54 | 透景生命 | 7.58% | -4.40% | 4.6分 |
| 56 | 易瑞生物 | 7.35% | 0.20% | 5.7分 |
| 58 | 超研股份 | 7.16% | -2.87% | 5.4分 |
| 60 | 开立医疗 | 6.86% | -3.23% | 5.3分 |
| 62 | 正海生物 | 6.37% | 2.20% | 4.9分 |
| 64 | 联影医疗 | 5.91% | -5.17% | 5.4分 |
| 66 | 中源协和 | 5.59% | -2.07% | 5.1分 |
| 68 | ST凯利 | 4.92% | 2.31% | 5.4分 |
| 70 | 昊海生科 | 4.67% | -0.13% | 5.5分 |
| 72 | 迪瑞医疗 | 4.56% | -1.31% | 4.9分 |
| 74 | 明德生物 | 4.23% | -0.53% | 4.5分 |
| 76 | 正川股份 | 4.13% | 0.74% | 5.7分 |
| 78 | 尚荣医疗 | 3.78% | -0.78% | 5.3分 |
| 80 | 山东药玻 | 3.54% | 2.48% | 5.1分 |
| 82 | 奥美医疗 | 3.31% | 1.11% | 5.8分 |
| 84 | 海利生物 | 3.19% | -1.07% | 5.0分 |
| 86 | 大博医疗 | 3.03% | -1.18% | 5.4分 |
| 88 | 黄山胶囊 | 2.87% | 0.90% | 5.5分 |
| 90 | 健帆生物 | 2.38% | -2.37% | 4.9分 |
| 92 | 达安基因 | 2.12% | -2.18% | 5.0分 |
| 94 | 康泰医学 | 2.06% | -2.40% | 4.9分 |
| 96 | 天益医疗 | 1.55% | 8.37% | 5.5分 |
| 98 | 迈瑞医疗 | 1.22% | -3.77% | 5.3分 |
| 100 | 科华生物 | 0.82% | -1.44% | 4.8分 |
| 102 | 南卫股份 | 0.16% | -1.11% | 5.4分 |
| 104 | 九安医疗 | -1.38% | -2.10% | 5.3分 |
| 106 | 惠泰医疗 | -1.51% | -3.92% | 5.7分 |
| 108 | 新产业 | -2.57% | -4.07% | 4.2分 |
| 110 | 英科医疗 | -4.63% | 8.08% | 5.3分 |
| 112 | 博拓生物 | -16.65% | -3.98% | 4.2分 |
| 114 | - | -18.04% | -3.33% | 分 |
| 116 | 康为世纪 | -23.75% | -0.18% | 6.1分 |
| 118 | 华强科技 | -50.70% | -2.39% | 4.3分 |
| 120 | 健信超导 | - | -0.94% | 5.9分 |
| 122 | 奕瑞科技 | - | 10.38% | 6.7分 |
| 124 | 安旭生物 | - | 0.97% | 5.4分 |
| 126 | 天臣医疗 | - | -3.39% | 5.6分 |
| 128 | 安图生物 | - | -0.80% | 6.3分 |
| 130 | 瑞迈特 | - | -5.64% | 5.3分 |
| 132 | 力诺药包 | - | -0.32% | 4.6分 |
| 134 | 东方海洋 | - | -2.90% | 4.7分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 97/248 ， 34/248。
[{"date":"2025-09-30","value":"0.39","vol":"2.98"},{"date":"2025-06-30","value":"0.18","vol":"2.34"},{"date":"2025-03-31","value":"0.03","vol":"1.16"},{"date":"2024-12-31","value":"2.27","vol":"0.56"},{"date":"2024-09-30","value":"1.61","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.39 | 0.18 | 0.03 | 2.27 | 1.61 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"66.60","vol":"51.73"},{"date":"2025-06-30","value":"65.66","vol":"52.04"},{"date":"2025-03-31","value":"63.66","vol":"51.41"},{"date":"2024-12-31","value":"66.15","vol":"52.51"},{"date":"2024-09-30","value":"64.94","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.60 | 65.66 | 63.66 | 66.15 | 64.94 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 111/248 ， 105/248。
[{"date":"2025-09-30","value":"-19.73","vol":"0.24"},{"date":"2025-06-30","value":"-26.25","vol":"-1.07"},{"date":"2025-03-31","value":"-19.53","vol":"-0.10"},{"date":"2024-12-31","value":"-19.53","vol":"1.15"},{"date":"2024-09-30","value":"-20.01","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-19.73 | -26.25 | -19.53 | -19.53 | -20.01 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-76.33","vol":"-15.37"},{"date":"2025-06-30","value":"-58.41","vol":"-18.14"},{"date":"2025-03-31","value":"110.51","vol":"-2.59"},{"date":"2024-12-31","value":"-61.37","vol":"-23.09"},{"date":"2024-09-30","value":"-43.16","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-76.33 | -58.41 | 110.51 | -61.37 | -43.16 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 101/248 ， 107/248。
[{"date":"2025-09-30","value":"0.14","vol":"0.25"},{"date":"2025-06-30","value":"0.09","vol":"0.17"},{"date":"2025-03-31","value":"0.04","vol":"0.08"},{"date":"2024-12-31","value":"0.25","vol":"0.36"},{"date":"2024-09-30","value":"0.19","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.09 | 0.04 | 0.25 | 0.19 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.79","vol":"1.66"},{"date":"2025-06-30","value":"0.52","vol":"1.12"},{"date":"2025-03-31","value":"0.25","vol":"0.55"},{"date":"2024-12-31","value":"1.09","vol":"2.32"},{"date":"2024-09-30","value":"0.78","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.79 | 0.52 | 0.25 | 1.09 | 0.78 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"37.37","vol":"14.75"},{"date":"2025-06-30","value":"59.24","vol":"15.16"},{"date":"2025-03-31","value":"21.91","vol":"4.21"},{"date":"2024-12-31","value":"46.09","vol":"29.34"},{"date":"2024-09-30","value":"25.84","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 37.37 | 59.24 | 21.91 | 46.09 | 25.84 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.20","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.20","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.20 | - | 1.20 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 113/248 ， 116/248。
[{"date":"2025-09-30","value":"11.00","vol":"5.66"},{"date":"2025-06-30","value":"8.26","vol":"5.47"},{"date":"2025-03-31","value":"13.95","vol":"5.84"},{"date":"2024-12-31","value":"7.00","vol":"5.30"},{"date":"2024-09-30","value":"10.47","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
11.00 | 8.26 | 13.95 | 7.00 | 10.47 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"9.18","vol":"4.51"},{"date":"2025-06-30","value":"6.90","vol":"4.35"},{"date":"2025-03-31","value":"11.08","vol":"4.73"},{"date":"2024-12-31","value":"5.45","vol":"4.27"},{"date":"2024-09-30","value":"8.59","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
9.18 | 6.90 | 11.08 | 5.45 | 8.59 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 50/248 ， 49/248。
[{"date":"2025-09-30","value":"23.63","vol":"22.07"},{"date":"2025-06-30","value":"13.17","vol":"22.01"},{"date":"2025-03-31","value":"10.33","vol":"21.19"},{"date":"2024-12-31","value":"13.20","vol":"21.94"},{"date":"2024-09-30","value":"9.82","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.63 | 13.17 | 10.33 | 13.20 | 9.82 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.32","vol":"0.71"},{"date":"2025-06-30","value":"0.15","vol":"0.58"},{"date":"2025-03-31","value":"0.12","vol":"0.56"},{"date":"2024-12-31","value":"0.15","vol":"0.55"},{"date":"2024-09-30","value":"0.11","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.32 | 0.15 | 0.12 | 0.15 | 0.11 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"1.61","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.25","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.89","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.35","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.09","blueLineValue":"0.05","type":"YC"}]